About this trial
The goal of this quasi-experimental single-arm trial is to evaluate whether a structured Frame Running training program can improve functional ability, participation, and quality of life in children and young people with physical disabilities. The study includes participants aged 8-18 years with cerebral palsy or other conditions causing physical disabilities.
The aim of the study is to investigate changes in the primary outcome measure; functional ability using the Pediatric Evaluation of Disability Inventory - Computer Adaptive Test (PEDI-CAT), and a series of secondary outcome measures on mobility capacity, physical endurance, performance of everyday activities, and health-related quality of life in children and young people with physical disabilities.
Participants will complete a 24-week training program carried out in community athletics clubs:
12-week low-intensity control period with one supervised weekly Frame Running session focused on familiarization.
12-week moderate-to-high intensity intervention period with two weekly training sessions, including warm-up, technique training, endurance and speed intervals, and participation-focused activities.
Data collection comprises four standardized questionnaires, four physical performance tests conducted at multiple time points, an electronic training diary, and Rating of Perceived Exertion-Pediatric Scale (RPE-P) obtained before and after selected endurance tests.
Eligibility criteria
Qualifiers
Children and adolescents aged 8-18 years.
Diagnosed with cerebral palsy (CP) or another condition resulting in a physical disability affecting mobility.
Some prior Frame Running experience, such as informal use or occasional training, but must not have taken part in structured, organized, or performance-oriented Frame Running training within the past 12 weeks.
Able to propel the Frame Running bike forward independently
Disqualifiers
Severe visual and/or cognitive impairments that would compromise safe participation
Known medical conditions that could limit or contraindicate involvement in the study (e.g., significant cardiovascular or pulmonary disease).
Trial design
Treatments tested in this trial
- Frame Running Training
Treatment groups
Sponsors and collaborators
Odense University Hospital
Lead sponsor
University of Southern Denmark
Collaborator